8-KThe WireStrategic
Exit / Disposal Costs · Company Update
Filed Apr 7, 2022 · 4y ago · Accession 0001193125-22-098113
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Akebia Therapeutics, Inc.
- Ticker
- AKBA
- CIK
- 1517022
- Form type
- 8-K
- Filing date
- Apr 7, 2022
- Report date
- Apr 1, 2022
- Document
- d314349d8k.htm
- Size
- 146 KB